Congenital cyanotic heart disease and headache.
May
M L A
ML
Department of Immunology and Infectious Diseases, The Children's Hospital at Westmead, Sydney, New South Wales, Australia. merytam@chw.edu.au
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001922:Brain Abscess / Q000150:complications / Q000382:microbiology; D002648:Child; D003490:Cyanosis / Q000150:complications* / Q000151:congenital*; D004359:Drug Therapy, Combination; D005436:Floxacillin / Q000627:therapeutic use; D006261:Headache / Q000150:complications* / Q000175:diagnosis / Q000209:etiology; D006331:Heart Diseases / Q000150:complications* / Q000151:congenital*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use; D009778:Occipital Lobe / Q000000981:diagnostic imaging / Q000382:microbiology / Q000473:pathology; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology; D014057:Tomography, X-Ray Computed
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D008795:Metronidazole; D005436:Floxacillin